Current Issue 3 February 2012, Vol. 586, No. 3

Issue Highlights

Research Letters with SDA

  • C-terminal residues of Oryza sativa GUN4 are required for the activation of the ChlH subunit of magnesium chelatase in chlorophyll synthesis
    3 February 2012(Vol. 586 | No. 3 | Pages 205-210)

    Shuaixiang Zhou, Artur Sawicki, Robert D. Willows, Meizhong Luo

  • FLU, a negative feedback regulator of tetrapyrrole biosynthesis, is physically linked to the final steps of the Mg++-branch of this pathway
    3 February 2012(Vol. 586 | No. 3 | Pages 211-216)

    Dominika Kauss, Sylvain Bischof, Sandro Steiner, Klaus Apel, Rasa Meskauskiene

  • Activation of macrophage-stimulating protein by human airway trypsin-like protease
    3 February 2012(Vol. 586 | No. 3 | Pages 217-221)

    Hiroshi Orikawa, Makiko Kawaguchi, Takashi Baba, Kenji Yorita, Sumio Sakoda, Hiroaki Kataoka

  • Insights into differential modulation of receptor function by hinge region using novel agonistic lutropin receptor and inverse agonistic thyrotropin receptor antibodies
    03 February 2012

    Ritankar Majumdar, Reema Railkar, Rajan R Dighe

  • Construction of synthetic regulatory networks in yeast
    03 February 2012

    Benjamin A. Blount, Tim Weenink, Tom Ellis

  • Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK
    03 February 2012

    Na Li, Bin Tang, En-Dong Zhu, Bo-sheng Li, Yuan Zhuang, Shu Yu, Dong-shui Lu, Quan-Ming Zou, Bin Xiao, Xu-Hu Mao

  • ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways
    03 February 2012

    Song Li, Chaoyang Xiong, Junjie Zhang

  • Pro42 and Val45 of Staphylokinase modulate intermolecular interactions of His43-Tyr44 pair and specificity of Staphylokinase-plasmin activator complex
    03 February 2012

    Satish Singh, Fnu Ashish, Kanak L. Dikshit

  • View More Articles in Press...



On the Cover


Cover Image

More About FEBS

FEBS, since its inception in 1964, has promoted life sciences and supported scientists in Europe and elsewhere, and is one of the largest not-for-profit organizations in life sciences today. Among the offers to our members are participation in advance courses, the support of fellowships and participation in our annual Congress. All activities related to FEBS are financed by income generated by our four publications: FEBS Letters, FEBS Journal, Molecular Oncology, and FEBS OpenBio. As reader or author of papers in these journals, you contribute to our mission: To foster scientific excellence and promote science for society. Thank you for your support. For more information on FEBS, please visit www.febs.org.

Publishing Information

FEBS Letters is published by Elsevier BV on behalf of the Federation of European Biochemical Societies.



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Announcements

FEBS Letters Structured Digital Abstracts Experiment

Protein interaction papers to have Structured Digital Summary

Read the Press Release for more details and explanation of this innovative experiment.

Past Announcements

Special Issues

      

Virtual Special Issues

FEBS Letters is proud to launch a new series of Virtual Special Issues which will highlight a collection of outstanding articles recently published in the journal, focusing on a selection of topics that we hope will be of general interest to our readers.